Complete Response of a Patient With Metastatic Sarcomatoid Renal Cell Carcinoma to a Programmed Death-1 Checkpoint Inhibitor

J Oncol Pract. 2018 Aug;14(8):511-513. doi: 10.1200/JOP.18.00213. Epub 2018 Jun 19.

Authors

Nemer El Mouallem¹, Steven C Smith¹, Asit K Paul¹

Affiliation

¹ Virginia Commonwealth University, Richmond, VA.

PMID: 29920137
DOI: 10.1200/JOP.18.00213

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antineoplastic Agents, Immunological / therapeutic use*
Carcinoma, Renal Cell / diagnostic imaging
Carcinoma, Renal Cell / drug therapy*
Humans
Kidney Neoplasms / diagnostic imaging
Kidney Neoplasms / drug therapy*
Male
Nivolumab / therapeutic use*
Positron Emission Tomography Computed Tomography
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
Treatment Outcome

Substances

Antineoplastic Agents, Immunological
PDCD1 protein, human
Programmed Cell Death 1 Receptor
Nivolumab